Back

Inhibition of SRSF4 in cardiomyocytes induces left ventricular hypertrophy

8 July 2016 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: Poster session 1 - Cardiomyopathies and fibrosis Cardiomyopathies Open Access Frontiers in CardioVascular Biology 2016 Council on Basic Cardiovascular Science

About the speaker

Photo
Mr Javier Larrasa-Alonso

National Centre for Cardiovascular Research (CNIC), Madrid (Spain)

12 More presentations in this session

Presentation thumbnail
Cardiomyopathies and fibrosis - Poster discussant:
Presentation thumbnail
Plakophilin-2 haploinsufficiency leads to impaired canonical Wnt signaling in ARVC patient
Doctor A. Khudiakov (Cusano Milanino, IT)
Abstract
Presentation thumbnail
Improved technique for customized, easier, safer and more reliable transverse aortic arch banding and debanding in mice as a model of pressure overload hypertrophy
Doctor J. Nistal (Santander, ES)
Abstract
Presentation thumbnail
Late sodium current inhibitors for the treatment of inducible obstruction and diastolic dysfunction in hypertrophic cardiomyopathy: a study on human myocardium.
Doctor C. Ferrantini (Florence, IT)
Abstract
Presentation thumbnail
Angiotensin II receptor antagonist fimasartan has protective role of left ventricular fibrosis and remodeling in the rat ischemic heart
Professor S. Park (Seoul, KR)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Cardiomyopathies and fibrosis

The Event

Event poster

Frontiers in CardioVascular Biology 2016

8 July - 10 July 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources